Health Allergan Aesthetics publishes ‘The Future of Aesthetics’ global trends report providing unrivalled insight into future of industry June 17, 2022
Health SKYRIZI® (risankizumab-rzaa) Receives FDA Approval as the First and Only Specific Interleukin-23 (IL-23) to Treat Moderately to Severely Active Crohn’s Disease in Adults June 17, 2022
Health Global Health Services Company, Cigna, Announces $3.5 Billion Accelerated Stock Repurchase Agreements June 16, 2022
Health AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know June 16, 2022
Search
Search
